-
Continue with Glenmark Life Sciences dosage in your portfolio, despite muted listing
Glenmark Life Sciences got listed at price to earnings of 26.01x compared to Divis Lab & Laurus Lab which are trading at 65.8x & 34.2x, respectively.
-
Glenmark Life Sciences IPO share allotment today: Here’s how to check status
Investors are now looking forward to the share allotment status. Investors can check their allotment status by using any one of the two methods
-
Day 1: Glenmark Life Sciences IPO subscribed 2.78 times
The issue received bids for 4,17,79,260 shares against 1,50,18,279 shares on offer, as per data available with the NSE
-
Glenmark Life Sciences IPO sails through
Geojit Financial Services assigned a “Subscribe” rating for the issue on a long-term basis considering its strong focus on R&D.
-
Sensex, Nifty may open in green
The domestic equity barometers ended a volatile session with modest losses on Monday.
-
Glenmark Life IPO opens tomorrow, things you must know
Ahead of the IPO, shares of Glenmark Life Sciences were trading at Rs 855 per share marking a premium of Rs 135 or 18.75% at the upper price band
-
Glenmark Life IPO to open on Tuesday; should you subscribe?
The public issue will have a fresh issue of equity shares worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma
-
Glenmark Life Sciences IPO: Nine things you must know
Glenmark Life Sciences IPO opens on July 27 and closes on July 29. The price band for the issue has been fixed at Rs 695-720 per share.
-
Glenmark Pharma arm files papers for IPO with SEBI
Glenmark Life Sciences has filed a Draft Red Herring Prospectus with SEBI for an initial public offer
